Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.
Journal: Experimental neurology
Published: January 13, 2020
Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 29, 2018
Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity.
Journal: NPJ Parkinson's disease
Published: December 14, 2017
Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contacts.
Journal: Journal of cellular and molecular medicine
Published: November 20, 2017
A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia.
Journal: Neuroscience and biobehavioral reviews
Published: April 27, 2017
D-512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats.
Journal: British journal of pharmacology
Published: March 20, 2017
Hexokinases link DJ-1 to the PINK1/parkin pathway.
Journal: Molecular neurodegeneration
Published: March 13, 2017
Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia.
Journal: Experimental neurology
Published: September 06, 2016
Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
Journal: Neuropharmacology
Published: May 05, 2016
The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: April 21, 2016
Last Updated: 09/26/2026